CADU-CREX FOLLICULAR ISLANDS LOSS DOUBLE TREATMENT PLC7 - PILUM-STEM - ABUNDANT LOSS FOR MEN

CADU-CREX FOLLICULAR ISLANDS LOSS DOUBLE TREATMENT

PLC7 - PILUM-STEM

Double Anti-Hair Loss Treatment with the high-concentration PLC7 complex and the Pilum-Stem complex.

A Transdermal Technology. Helps stop hair loss. Promotes re-growth. For single follicles and follicular islands

MAN - ABUNDANT FALL

Cadu-Crex Follicular Islands Fall PLC7 - Pilum-Stem is a dual treatment for topical use for cosmetic use that helps in a targeted way to slow the detachment of hair both from the stems present in the individual follicles and in the follicular islands, promoting their re-growth. The two treatments share the formulation base with the patented anti-hair loss complex (Hydroxyproline, Aspartic Acid, Enzyme Activator) with Taurine, which is associated with the active ingredients of Crescina Re-Growth HFSC and the Follicular Islands Fall complex (Alpha Lipoic Acid, Oligopeptide-41, Nonapeptide-22, Decapeptide-19, Calcium Chloride, Hypericum Perforatum Extract).

They also contain Transdermal Technology enhancers.

PLC7 - Hair loss treatment containing the high concentration complex of 7 plate-like molecules which contribute to intensifying the anti-hair loss action of the preparation. They are synthetic substances similar to the endogenous molecules present

naturally in the hair system:

sh-Polypeptide-11,

sh-Polypeptide-1,

sh-Oligopeptide-1,

sh-Polypeptide-2,

sh-Polypeptide-86,

sh-Polypeptide-8,

sh-Polypeptide-9.

PLC7

The complex is inserted into the patented Labo anti-fall base.

20 vials.

Pilum-Stem - Hair loss treatment containing the formulation evolution of

HSSC complex (Patent

Swiss CH 704 629) composed of Pentapeptide-31, Hydrolyzed Pea Extract and Laminaria Digitata Extract, combined with Phyllanthus Emblica Fruit extract, to help protect and maintain intact the environment of the reserve cells of the scalp and help the hair to resist

premature detachment.

The complex is inserted into the base

Labo patented anti-fall. 20 vials.

Transdermal Technology (Swiss Patent CH 711 466) allows the active molecules, thanks to the presence of 3 enhancers, to penetrate the hair system not only via the transfollicular route (opening of the follicle) but also transdermally through the skin layers of the scalp (ex vivo test with Franz Cells).

RECOMMENDATIONS FOR USE: The treatment contains 20 Cadu-Crex Follicular Islands PLC7 vials and 20 Cadu-Crex Follicular Islands Pilum-Stem vials to be used alternately (total 40 vials).

They contain 3.5 ml and are recommended for daily use for the first 5 days of the week with a two-day break. Follow the order in which the vials are placed in the slots. The 40 vials contained in the package allow a 2-month treatment. See application scheme.

Cadu-Crex is useful for preventing and counteracting the physiological, non-pathological causes of hair loss. It does not act on completely atrophied follicles.

Warning: EXTERNAL USE. DO NOT INJECT. DO NOT SWALLOW. Avoid contact with eyes and mucous membranes.

Labo International srl - Padua - Italy - Made in Italy - Ref. 04374/Rev. 00 - €20+20×3.5 ml